Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...
Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...
Scientists have identified molecules from blood and urine that may reveal how much energy a person consumes from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback